SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

HESTER BIOSCIENCES

BSE: 524669 28 Jun 2025
Healthcare
₹ 1760
Hester Biosciences Ltd specializes in Pharmaceuticals within the Healthcare sector.

HESTER BIOSCIENCES - Share Price & Details

Market Cap
₹1,488
High /Low
3,379 / 1,243
Stock P/E
54.1
Book Value
₹369.0
Dividend Yield
0.34
ROCE
9.62
ROE
₹9.07
Face Value
10.0
PEG Ratio
-57.6
EVEBITDA
₹24.5
Debt
213
CMP / FCF
322.0
Debt to equity
₹0.68
NP Ann
28.8
High price all time
3,379
Piotroski score
₹8.0
Graham Number
518.0
No. Eq. Shares
0.85
Net CF
₹-6.21
Net profit
28.8
Price to book value
4.73
Interest Coverage
₹4.12
Low price all time
28.7
Industry PE
32.0
Reserves
₹306
Free Cash Flow
₹44.2

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
HESTER BIOSCIENCES LTD.777.396.35766.7211.331,48854.1
BLISS GVS PHARMA LTD.1653.63114.521560.021.07145917.3
JAGSONPAL PHARMACEUTICALS LTD.613.365.83585.60.98142335.8

Peer Comparison Chart


About HESTER BIOSCIENCES

Hester Biosciences Ltd, with Security Code 524669, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Animal Biotechnology Market Deep Research with Forecast

(09 Jun 2025)
Press release - Coherent Market Insights - Animal Biotechnology Market Deep Research with Forecast By 2025-2032 | Heska Corporation,...
Read more →

FIIs Bought 23,613 Shares: This Bioscience Company Advances Rs 176 Crore Facility and Plans Early Launch of Avian Influenza Vaccine in Q2FY26

(16 May 2025)
Hester Biosciences is advancing on several strategic fronts in FY26, with a clear focus on operational efficiency, capacity enhancement,...
Read more →

Hester Biosciences Shows Signs of Recovery Amid Mixed Market Signals in Pharmaceuticals

(12 May 2025)
Hester Biosciences experienced a notable performance on May 12, 2025, reversing a two-day decline with a significant intraday high.
Read more →

Hester Biosciences Ltd (BOM:524669) Q4 2025 Earnings Call Highlights: Strong Profit Growth ... By GuruFocus

(10 May 2025)
Hester Biosciences Ltd (BOM:524669) reported a 70% profit growth for FY25 and 30% in Q4 on a standalone basis.
Read more →

Hester Biosciences registers 30% YoY jump in Q4 PAT PAT to Rs 9.6 crore

(09 May 2025)
The animal healthcare company has reported 30% jump in standalone net profit to Rs 9.63 crore on a 5% increase in revenue from operations to...
Read more →

Hester Biosciences consolidated net profit declines 73.94% in the March 2025 quarter

(09 May 2025)
Sales rise 3.37% to Rs 81.93 crore. Net profit of Hester Biosciences declined 73.94% to Rs 1.29 crore in the quarter ended March 2025 as...
Read more →